Back
Dianthus Therapeutics Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Sell
1
DNTH
Dianthus Therapeutics
Last Price:
20.68
Seasonality Move:
12.89%
Sell
39
REGN
Regeneron Pharmaceuticals
Last Price:
744.33
Seasonality Move:
14.6%
Sell
1
Dianthus Therapeutics (DNTH)
is a Sell
Is Dianthus Therapeutics a Buy, Sell or Hold?
- The current Dianthus Therapeutics [DNTH] share price is $20.77. The Score for DNTH is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- DNTH is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $743.35. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DNTH Stock Price Chart
What is Dianthus Therapeutics's stock price today?
-
The Dianthus Therapeutics share price today is $20.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNTH is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $743.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.
DNTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.34 | Sell |
| Relative Strength Index (14 RSI): | 23.86 | Sell |
| Chaikin Money Flow: | -146216 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.88 - 29.38) | Sell |
| Bollinger Bands (100): | (26.17 - 29.09) | Sell |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -62 | Sell |
| Relative Strength Index (14 RSI): | 13.08 | Sell |
| Chaikin Money Flow: | 151 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (783.29 - 941.63) | Sell |
| Bollinger Bands (100): | (917.99 - 1161.21) | Sell |
DNTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.66 | Sell |
| 20-day SMA: | 26.9 | Sell |
| 50-day SMA: | 27.25 | Sell |
| 200-day SMA: | 26.2 | Sell |
| 8-day EMA: | 24.1 | Sell |
| 20-day EMA: | 26.01 | Sell |
| 50-day EMA: | 26.96 | Sell |
| 200-day EMA: | 24.96 | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 780.04 | Sell |
| 20-day SMA: | 834.53 | Sell |
| 50-day SMA: | 964.64 | Sell |
| 200-day SMA: | 1003.34 | Sell |
| 8-day EMA: | 775.42 | Sell |
| 20-day EMA: | 832.12 | Sell |
| 50-day EMA: | 927.66 | Sell |
| 200-day EMA: | 978.17 | Sell |
Dianthus Therapeutics Earnings Growth & DNTH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.42 per share, and an increase next year of $0.41 per share.
Dianthus Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||